ACM
RPRX icon

Aubrey Capital Management’s Royalty Pharma RPRX Stock Holding History

Aubrey Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,243
Closed -$346K – 66
2024
Q3 		$346K Sell
12,243
-13,216
-52% -$366K 0.13% 48
2024
Q2 		$536K Sell
25,459
-5,160
-17% -$143K 0.21% 44
2024
Q1 		$736K Sell
30,619
-2,472
-7% -$72.9K 0.26% 40
2023
Q4 		$926K Buy
+33,091
New +$909K 0.39% 41
2022
Q4 		– Sell
-15,600
Closed -$629K – 54
2022
Q3 		$629K Buy
15,600
+5,500
+54% +$235K 0.54% 26
2022
Q2 		$430K Hold
10,100
– – 0.35% 35
2022
Q1 		$394K Buy
+10,100
New +$397K 0.23% 47

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return